Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral liothyronine for outcomes after congenital cardiac surgery
IRCT20180502039507N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of liothyronine in euthyroid sick syndrome (NTIS) (4 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Length of ICU hospitalization, Duration of intubation and 1 more. Started Jun 2018; status: completed.
02
Drugs
liothyronine
03
Conditions
euthyroid sick syndrome (NTIS)
Beyond the preview
Go deeper on IRCT20180502039507N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180502039507N1.